Home › Crohn's Disease › Minnesota
Crohn's Disease clinical trials in Minnesota
11 studies for Crohn's Disease are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Mayo Clinic in Rochester, Minnesota ( Site 5024), Rochester
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 2, 2026 · NCT06430801Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Mayo Clinic-Rochester /ID# 265550, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06548542A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Mayo Clinic 1, Rochester
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07196722A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- MNGI Digestive Health, P. A. /ID# 255366, Minneapolis
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 23, 2026 · NCT05995353Standardized Microbiota Transplant Therapy in Crohn's Disease
- University of Minnesota, Minneapolis
RecruitingPhase 2
Ages 18 to 89 · All sexes · Updated Sep 8, 2026 · NCT06631586Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- MNGI Digestive Health, P. A. /ID# 262204, Minneapolis
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Jun 24, 2026 · NCT06332534A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- MNGI Digestive Health, PA, Minneapolis
- Mayo Clinic - PIN, Rochester
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated May 5, 2026 · NCT0477932068Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
- Mayo Clinic, Rochester
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT07273188Treatment of Moderate to Severe Refractory Crohn's Disease
- Mayo Clinic Rochester, Rochester
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Dec 10, 2025 · NCT06721962Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
- Mayo Clinic- Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2025 · NCT06670638Helmsley 3.0: Abbreviated MRE
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 10 and older · All sexes · Updated Oct 27, 2025 · NCT06533228From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.